HPP

Tru Earth Donates $2M Worth of Everyday Essentials to Communities in Need This Holiday Season

Retrieved on: 
Tuesday, December 19, 2023
Partnership, Food, Homelessness, Greater Vancouver Food Bank, Greater, B Corporation (certification), Holiday, HPP, COVID-19, Pregnancy, Poverty, Capitalism, Mother, Organization

VANCOUVER, BC, Dec. 19, 2023 /PRNewswire/ -- Today, Tru Earth announced a two-fold donation totaling $2M CAD worth of everyday essentials to the Homeless Prenatal Program (HPP) in San Francisco and the Greater Vancouver Food Bank in Canada. The assortment of products, which include reusable shopping bags, lunch kits and beeswax wraps, among other items, will benefit homeless mothers, pregnant women and families facing food insecurity served by the two organizations.

Key Points: 
  • VANCOUVER, BC, Dec. 19, 2023 /PRNewswire/ -- Today, Tru Earth announced a two-fold donation totaling $2M CAD worth of everyday essentials to the Homeless Prenatal Program (HPP) in San Francisco and the Greater Vancouver Food Bank in Canada.
  • "There is unfortunately an increasing need to support our neighbors in need across North America, and beyond.
  • "We are thrilled and grateful to receive this donation from Tru Earth, which will help our client base worry about one less thing this holiday season."
  • "The holiday season is a great time to kick off giving, but these issues affecting San Francisco and Vancouver communities don't stop after the holidays," said Liski.

United States Private Label Beverages and Contract Packing Market Report 2023 Featuring Refresco Group, Dairy Farmers of America, Louis Dreyfus Citrus, and Niagara Bottling - ResearchAndMarkets.com

Retrieved on: 
Friday, December 8, 2023
Packaging, Retail, Manufacturing, Food, Beverage, Aluminium, Glass, Drink, Beer, HPP, Wine, Niagara Bottling, Directory, HDPE, PET, Asepsis, Research report, Bottled water

The "2023 Private Label Beverages and Contract Packing in the U.S." report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2023 Private Label Beverages and Contract Packing in the U.S." report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.
  • This research report offers insight into private label beverage market production, quantifies the private label vs. branded market, offers representative pricing, sheds light on issues related to contract packing and discusses the trends affecting the private label and contract packing industry.
  • An overview of the major suppliers of private label beverages in the U.S. including Refresco, Dairy Farmers of America, Louis Dreyfus Citrus, Niagara Bottling and others.
  • Average pricing of contract packing for conversion only as well as full product contracts and full-product cost makeup and contract packing contract issues.

Hiperbaric to Showcase HPP Technology at Inaugural Seafood Industry Innovation Summit

Retrieved on: 
Tuesday, November 7, 2023
Food safety, Aquaculture, Atlantic Canada, Offshore drilling in Atlantic Canada, Marine Institute of Memorial University of Newfoundland, Mary Brown, SIIS, Summit, HPP, CASD, NL, Mary Brown's, CCFI, Fishery, Automation, Fishing, Whaling

"HPP is an ideal technology for seafood processors looking to extend shelf life, ensure food safety, automate shucking operations, and develop value-add, clean-label seafood products that meet consumer demand for freshness and convenience."

Key Points: 
  • "HPP is an ideal technology for seafood processors looking to extend shelf life, ensure food safety, automate shucking operations, and develop value-add, clean-label seafood products that meet consumer demand for freshness and convenience."
  • As a summit sponsor, Hiperbaric will showcase its industry-leading HPP solutions for food safety and shucking automation through a plenary session, pilot plant demo, and new product development workshop.
  • "This technology has tremendous potential to drive innovation in our sector while supporting the productivity, profitability, and sustainability of Atlantic Canadian seafood."
  • Registration for the Seafood Innovation Summit includes free passes to the North Atlantic Fish and Workboat Show, November 17 & 18 at Mary Brown's Centre, St. John's.

Hudson Pacific Properties Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 1, 2023
Commercial Building & Real Estate, Construction & Property, REIT, NYSE, Block, Hudson Pacific Properties, Sunset, GAAP, Acquisition, Vornado, FFO, Tenant, Growth, HPP, NOI, Green star, Total, Blackstone, Don Quixote, Film industry, Security (finance), Commercial property, Lease, Sunset Las Palmas Studios

Hudson Pacific Properties, Inc. (NYSE: HPP) (the "Company," "Hudson Pacific," or "HPP"), a unique provider of end-to-end real estate solutions for dynamic tech and media tenants, today announced financial results for the third quarter 2023.

Key Points: 
  • Hudson Pacific Properties, Inc. (NYSE: HPP) (the "Company," "Hudson Pacific," or "HPP"), a unique provider of end-to-end real estate solutions for dynamic tech and media tenants, today announced financial results for the third quarter 2023.
  • We also remain vigilant in controlling expenses and continue to focus on deleveraging and further fortifying our balance sheet while proactively managing our debt maturities.
  • There were no specified items for the third quarter 2023.
  • There can be no assurance that actual results will not differ materially from these estimates.

Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team

Retrieved on: 
Tuesday, October 24, 2023
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, OrbiMed, Hypophosphatasia, Alexion, HealthCap, General partnership, MBA, Electro-technical officer, Code, HPP, Disease, CSL Behring, Safety, HALO, Patient, DNA, Vaccine, Pharmaceutical industry, Rampart

Rampart Bioscience, Inc., a biotechnology company developing next-generation biologics, today announced an $85 million Series A financing to create medicines that aim to unburden patients from disease and their treatments.

Key Points: 
  • Rampart Bioscience, Inc., a biotechnology company developing next-generation biologics, today announced an $85 million Series A financing to create medicines that aim to unburden patients from disease and their treatments.
  • The new financing builds on an initial $40 million seed investment from OrbiMed.
  • The Rampart team has tremendous heart and a fierce commitment to reshaping the treatment landscape for those in dire need of better options,” said Louis Breton, Rampart Co-founder, Chief Executive Officer, and Board Director.
  • “Rampart’s DNA medicines contain novel structural elements that drive nuclear trafficking and retention while avoiding immune responses,” said Jeffrey Bartlett, Ph.D., Rampart Co-founder and Chief Innovation and Technical Officer.

AM-Pharma Announces Positive Clinical Data From Phase 1b Study Evaluating Ilofotase Alfa in Hypophosphatasia Patients

Retrieved on: 
Wednesday, October 11, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Bone disease, Vancouver Convention Centre, Pharmacokinetics, Doctor of Philosophy, Biomarker, MD, Society, Data, DSM-IV codes, PLP, Safety, University, ALPL, Disease, Arthropathy, Patient, HPP, PDT, Enzyme, Pyrophosphate, Hypophosphatasia, American Society for Bone and Mineral Research, Muscle weakness, Enzyme replacement therapy, Pharmaceutical industry

AM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacement therapy in adult hypophosphatasia (HPP) patients.

Key Points: 
  • AM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacement therapy in adult hypophosphatasia (HPP) patients.
  • Patients were followed for 10 days after dosing to evaluate changes in the biochemical fingerprint of HPP, safety and tolerability.
  • In addition, ilofotase alfa was well-tolerated with pharmacokinetics consistent with observations from previous clinical studies.
  • "The encouraging early results confirming dose-dependent reductions of PLP and PPi levels upon treatment with ilofotase alfa underline the compound's therapeutic potential in that indication and I'm looking forward to evaluating ilofotase alfa in next stage clinical studies."

AM-Pharma Announces Updated Clinical Development Strategy

Retrieved on: 
Tuesday, September 26, 2023
Pharmaceutical, Health, Clinical Trials, Workforce, HPP, Facial muscles, AKI, Sepsis, Disorder, Patient, Risk, Hypophosphatasia, Supervisory board, Enzyme replacement therapy, Safety, Pharmaceutical industry

AM-Pharma B.V. today announced an updated clinical development strategy to evaluate ilofotase alfa in two indications.

Key Points: 
  • AM-Pharma B.V. today announced an updated clinical development strategy to evaluate ilofotase alfa in two indications.
  • The company’s proprietary compound ilofotase alfa is a recombinant alkaline phosphatase with an extensive clinical record and proven safety profile.
  • “Juliane’s expertise in clinical and corporate development, together with her experience as AM-Pharma’s COO over the past four years, will be extremely useful as the company pursues its development strategy.
  • AM-Pharma’s revised clinical strategy is backed by existing investors who have provided additional funding.

HPPY Skin Launches Refrigerated Skincare Line with State-of-the-Art Food Technology

Retrieved on: 
Monday, September 18, 2023
Honey, Food, HPP, Interview, Food industry, Skin care, Overalls, SKIN, Skin, Nutrient, Hyaluronic acid, Aloe vera, Cosmetics, Spirulina, Caffeine

PLEASANT PRAIRIE, Wis., Sept. 18, 2023 /PRNewswire/ -- Today HPPY Skin launches its clean skincare line with their debut product, the Refresh Mask, a cold-pressed cryo-facial mask.

Key Points: 
  • PLEASANT PRAIRIE, Wis., Sept. 18, 2023 /PRNewswire/ -- Today HPPY Skin launches its clean skincare line with their debut product, the Refresh Mask, a cold-pressed cryo-facial mask.
  • HPPY Skin is the first and only refrigerated skincare brand made with high pressure processing technology to produce effective, nutrient-rich formulas, without preservatives.
  • HPPY Skin is the first skincare brand to use high-pressure processing cold-water technology from the food industry, otherwise known as "HPP," to preserve the nutrients in their products.
  • HPPY Skin plans to expand their offerings with other innovative products including serums, toners, moisturizers, and cleansers, all made with highly effective skincare actives that retain and even increase their bioavailability over time with advanced food technology.

Hiperbaric and CSIRO Develop New Canister for High Pressure Thermal Processing (HPTP)

Retrieved on: 
Friday, September 15, 2023
Pressure, HPHT, Business development, Wellcome Trust Principal Research Fellow, Food, HPP, Drink, Food preservation, Nutrient, Research, Temperature, Sterilization, PACK, CSIRO, Spore, Safety, Convenience food

MIAMI, Sept. 15, 2023 /PRNewswire/ -- Hiperbaric , the global leader in high pressure technologies, is pleased to give an exclusive first look at an innovation that will transform food processing and preservation - High Pressure Thermal Processing (HPTP).

Key Points: 
  • MIAMI, Sept. 15, 2023 /PRNewswire/ -- Hiperbaric , the global leader in high pressure technologies, is pleased to give an exclusive first look at an innovation that will transform food processing and preservation - High Pressure Thermal Processing (HPTP).
  • Invented by CSIRO Australia's national science agency, and further developed by Hiperbaric, HPTP combines the microbial lethality of heat with the rapid speed of high pressure into one revolutionary system.
  • At the core of HPTP is a canister patented by CSIRO that adds mild heat to existing Hiperbaric High Pressure Processing (HPP) machines.
  • The process is simple and compatible with all existing Hiperbaric HPP machines - preheat the canister and food, hermetically seal, then use ultra-high pressure to rapidly achieve sterilization temperatures.

Pangea Natural Foods Inc. Provides Comprehensive Corporate Update

Retrieved on: 
Thursday, September 14, 2023
Taste, Glory, HPP, Q3, Zinc, Marketing, Farmer, Supermarket, Hormone, Boston Pizza, Acquisition, Iron, Environment, Agreement, Calder Memorial Trophy, Culture, Starbucks, Magnesium, GMO, Attention, Athlete, Air Canada, Internet, Canadian Food Inspection Agency, Knowledge, Growth, Netflix, CSE, Manganese, Antisocial, Sugar, National Hockey League, Food, Calcium, CCOF, White Rock, Partnership, Save-On-Foods, NHL, Vitamin E, Coal Harbor, Genetically modified organism, Columbia, WestJet, Health, Vancouver Canucks, Wine, Food delivery, Distribution (marketing), Retail, Hotel, Management, Dietary supplement, Bottled water, Tea, Subway, Pangaea

We not only co-pack products but also maintain the highest standards in food quality," said Pratap Sandhu, chief executive officer and founder at Pangea Natural Foods.

Key Points: 
  • We not only co-pack products but also maintain the highest standards in food quality," said Pratap Sandhu, chief executive officer and founder at Pangea Natural Foods.
  • Pangea Natural Foods' efficient production processes and economies of scale enable significant cost reductions for partners.
  • Pangea Natural Foods is excited about the future of its co-packing services and the opportunities it brings for both the company and its partners.
  • Pangea Natural Foods looks forward to forging strong partnerships with third party food and beverage companies in British Columbia and across Canada.